Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.
about
Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.Characterization of three new serous epithelial ovarian cancer cell lines.BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.Establishment of a New Ovarian Cancer Cell Line CA5171Expression of cyclin D1 correlates with malignancy in human ovarian tumoursResponse to microtubule-interacting agents in primary epithelial ovarian cancer cellsIn vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies.Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts.Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites.
P2860
Q33259527-D9B63042-E98F-4E1B-9501-239539476A56Q33338286-A63FA971-21DC-463D-B67B-DE04C322CC9EQ33930051-0F051A7E-74C2-492A-8347-51ECCB9EDF29Q35683173-9EE3E3BA-A96A-45FA-B12C-223D9A29EC4FQ35853156-19DF7B3B-5FDF-4FC9-A5B3-BE96EA7B7107Q36431722-8E57056E-6BE6-46A6-AB8E-4CCDD34378D0Q37014519-8D2705E7-C655-47A3-8307-0B485FFD5F9DQ37621597-3C4D7621-4CA3-45CE-82FD-81951FA077AAQ37687254-7F1E5600-65BC-4568-81BB-F46CE86FB5DEQ38714246-4A1C8B7F-FA62-4195-87BE-D8A2E326ECF6Q38743426-4F71D3A5-1A2A-47FB-9135-34B22B499E44Q39185534-5D5A140A-1DDD-4AF2-9627-FE5E5C6C31A5Q39413185-0B318EB4-7BE2-49DF-AF99-3F85E3F003BAQ40773704-F3E44956-78B8-42FC-832D-275B9483D9C5Q52815240-B664AA44-52B8-40D9-AB66-9D1833B53934Q55066691-C8EFAFEB-F1AB-4F6C-A4A1-6A20000A9BAB
P2860
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Establishment and characteriza ...... s of human ovarian carcinomas.
@en
Establishment and characteriza ...... s of human ovarian carcinomas.
@nl
type
label
Establishment and characteriza ...... s of human ovarian carcinomas.
@en
Establishment and characteriza ...... s of human ovarian carcinomas.
@nl
prefLabel
Establishment and characteriza ...... s of human ovarian carcinomas.
@en
Establishment and characteriza ...... s of human ovarian carcinomas.
@nl
P2093
P4510
P356
P1433
P1476
Establishment and characteriza ...... s of human ovarian carcinomas.
@en
P2093
Noviello E
P356
10.1006/GYNO.1996.0194
P407
P577
1996-07-01T00:00:00Z